微小RNA与急性髓系白血病:治疗意义与新概念
急性髓系白血病(AML)是一种致命的血液系统恶性肿瘤,其特征为未成熟髓系细胞不受控制地生长。微小RNA(miRNA)是一类进化上保守的小非编码RNA,通过转录后调控信使RNA靶标发挥重要生理作用。过去十年的研究已识别miRNA在AML疾病发展的几乎所有方面发挥作用,包括细胞增殖、存活和分化;这些观察推动了miRNA作为疾病生物标志物的研究,以及通过治疗性操控miRNA来改善AML疾病结局的持续努力。尽管关于miRNA在AML疾病起始和进展中的重要性已了解很多,但仍有许多未解答的问题和miRNA生物学的新兴方面增加了其在AML中角色的复杂性。
要点
- miRNA在AML的细胞增殖、存活和分化等几乎所有方面发挥作用。
- miRNA正被研究作为AML的疾病生物标志物。
- 治疗性操控miRNA以改善AML结局的研究正在进行中。
核心结论
- 尽管关于miRNA在AML疾病起始和进展中的重要性已了解很多,但仍有许多未解答的问题和miRNA生物学的新兴方面增加了其在AML中角色的复杂性。
研究设计与样本
- 综述:总结miRNA在AML疾病发展中的作用及治疗意义。
主要发现
- miRNA在AML的细胞增殖、存活和分化中发挥作用。
- miRNA正被研究作为AML的疾病生物标志物。
- 治疗性操控miRNA以改善AML结局的研究正在进行中。
临床怎么用
- 原文未据此给出推荐。
局限性
- 仍有许多未解答的问题和miRNA生物学的新兴方面增加了其在AML中角色的复杂性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acute myeloid leukemia (AML) is a deadly hematologic malignancy characterized by the uncontrolled growth of immature myeloid cells. Over the past several decades, we have learned a tremendous amount regarding the genetic aberrations that govern disease development in AML. Among these are genes that encode noncoding RNAs, including the microRNA (miRNA) family. miRNAs are evolutionarily conserved small noncoding RNAs that display important physiological effects through their posttranscriptional regulation of messenger RNA targets. Over the past decade, studies have identified miRNAs as playing a role in nearly all aspects of AML disease development, including cellular proliferation, survival, and differentiation. These observations have led to the study of miRNAs as biomarkers of disease, and efforts to therapeutically manipulate miRNAs to improve disease outcome in AML are ongoing. Although much has been learned regarding the importance of miRNAs in AML disease initiation and progression, there are many unanswered questions and emerging facets of miRNA biology that add complexity to their roles in AML. Moving forward, answers to these questions will provide a greater level of understanding of miRNA biology and critical insights into the many translational applications for these small regulatory RNAs in AML.
引用
- Wallace JA, O'Connell RM. MicroRNAs and acute myeloid leukemia: therapeutic implications and emerging concepts. Blood. 2017. PMID: 28751524. doi:10.1182/blood-2016-10-697698
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。